Corrigendum to “N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: Impact of small structural modifications on P-gp recognition and CNS penetration” [Bioorg. Med. Chem. Lett. 19 (2009) 5078]
Florian Wakenhut, Gill A. Allan, Paul V. Fish, M. Jonathan Fray, Anthony C. Harrison, Rachel McCoy, Stephen C. Phillips, Thomas Ryckmans, Alan Stobie, Dominique Westbrook, Simon L. Westbrook, Gavin A.Volume:
20
Year:
2010
Language:
english
DOI:
10.1016/j.bmcl.2009.11.096
File:
PDF, 96 KB
english, 2010